HMFG1 ANTIGEN - A NEW MARKER FOR CARCINOMATOUS MENINGITIS

被引：16
作者：
MOSELEY, RP
OGE, K
SHAFQAT, S
MOSELEY, CM
SULLIVAN, NM
BADLEY, RA
BURCHELL, J
TAYLORPAPADIMITRIOU, J
COAKHAM, HB
机构：
[1] FRENCHAY HOSP,DEPT NEUROSURG,BRISTOL BS16 1LE,AVON,ENGLAND
[2] UNILEVER RES LABS,COLWORTH LAB,SHARNBROOK MK44 1LQ,BEDS,ENGLAND
[3] IMPERIAL CANC RES FUND,DEPT EPITHELICAL CELL BIOL,LONDON WC2A 3PX,ENGLAND
来源：
INTERNATIONAL JOURNAL OF CANCER | 1989年 / 44卷 / 03期
关键词：
D O I：
10.1002/ijc.2910440310
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：440 / 444
页数：5
相关论文
共 50 条
[41]   Cerebrospinal fluid tumor marker levels in predicting response to treatment and survival of carcinomatous meningitis in patients with advanced breast cancer [J].
Kosmas, C ;
Tsavaris, NB ;
Tsakonas, G ;
Soukouli, G ;
Gassiamis, A ;
Mylonakis, N ;
Karabelis, A .
MEDICAL SCIENCE MONITOR, 2005, 11 (08) :CR398-CR401
[42]   ANTIBODY GUIDED TARGETING OF NON-SMALL CELL LUNG-CANCER USING IN-111-LABELED HMFG1 F(AB')2 FRAGMENTS [J].
KALOFONOS, HP ;
SIVOLAPENKO, GB ;
COURTENAYLUCK, NS ;
SNOOK, DE ;
HOOKER, GR ;
WINTER, R ;
MCKENZIE, CG ;
TAYLORPAPADIMITRIOU, JJ ;
LAVENDER, PJ ;
EPENETOS, AA .
CANCER RESEARCH, 1988, 48 (07) :1977-1984
[43]   TENNESSEE ANTIGEN - NEW TUMOR MARKER [J].
JORDAN, TA ;
POTTER, TP ;
JORDAN, JD ;
JOHNSTON, K ;
LASATER, HA .
FEDERATION PROCEEDINGS, 1979, 38 (03) :1070-1070
[44]   TENNESSEE ANTIGEN - A NEW CANCER MARKER [J].
JORDAN, TA ;
CHI, DS ;
JORDAN, JD ;
POTTER, TP .
TUMOR BIOLOGY, 1987, 8 (06) :310-311
[45]   New rapid antigen test for diagnosis of pneumococcal meningitis [J].
Marcos, MA ;
Martínez, E ;
Almela, M ;
Mensa, J ;
de Anta, MTJ .
LANCET, 2001, 357 (9267) :1499-1500
[46]   Consolidation therapy with intraperitoneal R1549 (yttrium-90-labeled HMFG1 murine monoclonal antibody) in epithelial ovarian cancer: A phase III trial [J].
Oyen, W ;
Massuger, L ;
Verheijen, R ;
Seiden, M ;
Benigno, B ;
Lopes, A ;
Soper, J ;
Markowska, J ;
Vyzula, R ;
Lambert, H ;
Epenetos, A .
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2004, 19 (04) :528-528
[47]   Changes of cerebrospinal fluid tumor marker levels may predict response to treatment and survival of carcinomatous meningitis in patients with advanced breast cancer [J].
Christos Kosmas ;
Nicolas B. Tsavaris ;
Georgia Soukouli ;
Panagiotis Gouveris ;
George Tsakonas ;
John Katselis ;
Heraklis Alexopoulos ;
Nicolas Mylonakis ;
Athanasios Karabelis .
Medical Oncology, 2005, 22 :123-128
[48]   CARCINOEMBRYONIC ANTIGEN - NEW APPLICATIONS FOR AN OLD MARKER [J].
NORTON, JA .
ANNALS OF SURGERY, 1991, 213 (02) :95-97
[49]   THE SPECIFIC PROSTATIC ANTIGEN - A NEW TUMORAL MARKER [J].
ROBLES, JM ;
MORELL, AR .
MEDICINA CLINICA, 1985, 85 (19) :801-804
[50]   Changes of cerebrospinal fluid tumor marker levels may predict response to treatment and survival of carcinomatous meningitis in patients with advanced breast cancer [J].
Kosmas, C ;
Tsavaris, NB ;
Soukouli, G ;
Gouveris, P ;
Tsakonas, G ;
Katselis, J ;
Alexopoulos, H ;
Mylonakis, N ;
Karabelis, A .
MEDICAL ONCOLOGY, 2005, 22 (02) :123-128
12345